thiotepa has been researched along with Brill-Symmers Disease in 2 studies
Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fenske, TS | 1 |
Kahl, BS | 1 |
Eickhoff, J | 1 |
Mitchell, TL | 1 |
Smith, EP | 1 |
Atkinson, E | 1 |
McCoy, AG | 1 |
Eckstein, L | 1 |
Flynn, B | 1 |
McMannes, J | 1 |
Howard, S | 1 |
Longo, WL | 1 |
Tarella, C | 1 |
Zanni, M | 1 |
Magni, M | 1 |
Benedetti, F | 1 |
Patti, C | 1 |
Barbui, T | 1 |
Pileri, A | 1 |
Boccadoro, M | 1 |
Ciceri, F | 1 |
Gallamini, A | 1 |
Cortelazzo, S | 1 |
Majolino, I | 1 |
Mirto, S | 1 |
Corradini, P | 1 |
Passera, R | 1 |
Pizzolo, G | 1 |
Gianni, AM | 1 |
Rambaldi, A | 1 |
2 other studies available for thiotepa and Brill-Symmers Disease
Article | Year |
---|---|
Excessive toxicity of the high dose thiotepa and etoposide regimen when combined with radiation: Long-term autologous transplantation experience in follicular and mantle cell lymphoma.
Topics: Adult; Aged; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cel | 2005 |
Rituximab improves the efficacy of high-dose chemotherapy with autograft for high-risk follicular and diffuse large B-cell lymphoma: a multicenter Gruppo Italiano Terapie Innnovative nei linfomi survey.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplas | 2008 |